Evidence map›Paper›PMID 25971967›Full record

ArticleThe Journal of biological chemistry2015

Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION.

Muhammad Yasir Asghar, Melissa Magnusson, Kati Kemppainen, Pramod Sukumaran, Christoffer Löf, Ilari Pulli, Veronica Kalhori, Kid Törnquist

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Muhammad Yasir AsgharFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland.
Melissa MagnussonFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland.
Kati KemppainenFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland.
Pramod Sukumaranthe Department of Biochemistry and Molecular Biology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota 58201.
Christoffer LöfDepartment of Physiology, Institute of Biomedicine, University of Turku, 20520 Turku, Finland, and.
Ilari PulliFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland.
Veronica KalhoriFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum Helsinki, 00270 Helsinki, Finland.
Kid TörnquistFrom the Department of Biosciences, Åbo Akademi University, 20520 Turku, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum Helsinki, 00270 Helsinki, Finland ktornqvi@abo.fi.
Åbo Akademi University · FIMinerva Foundation · FIUniversity of North Dakota · USUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identity of calcium channels in the thyroid is unclear. In human follicular thyroid ML-1 cancer cells, sphingolipid sphingosine 1-phosphate (S1P), through S1P receptors 1 and 3 (S1P1/S1P3), and VEGF receptor 2 (VEGFR2) stimulates migration. We show that human thyroid cells express several forms of transient receptor potential canonical (TRPC) channels, including TRPC1. In TRPC1 knockdown (TRPC1-KD) ML-1 cells, the basal and S1P-evoked invasion and migration was attenuated. Furthermore, the expression of S1P3 and VEGFR2 was significantly down-regulated. Transfecting wild-type ML-1 cells with a nonconducting TRPC1 mutant decreased S1P3 and VEGFR2 expression. In TRPC1-KD cells, receptor-operated calcium entry was decreased. To investigate whether the decreased receptor expression was due to attenuated calcium entry, cells were incubated with the calcium chelator BAPTA-AM (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid). In these cells, and in cells where calmodulin and calmodulin-dependent kinase were blocked pharmacologically, S1P3 and VEGFR2 expression was decreased. In TRPC1-KD cells, both hypoxia-inducible factor 1α expression and the secretion and activity of MMP2 and MMP9 were attenuated, and proliferation was decreased in TRPC1-KD cells. This was due to a prolonged G1 phase of the cell cycle, a significant increase in the expression of the cyclin-dependent kinase inhibitors p21 and p27, and a decrease in the expression of cyclin D2, cyclin D3, and CDK6. Transfecting TRPC1 to TRPC1-KD cells rescued receptor expression, migration, and proliferation. Thus, the expression of S1P3 and VEGFR2 is mediated by a calcium-dependent mechanism. TRPC1 has a crucial role in this process. This regulation is important for the invasion, migration, and proliferation of thyroid cancer cells.

Indexed as

Cell ProliferationCell MovementCyclin D2Cyclin-Dependent KinasesHumansReceptors, LysosphingolipidReceptors, Vascular Endothelial Growth FactorSphingolipidsThyroid NeoplasmsTRPC Cation ChannelsVascular Endothelial Growth Factor Receptor-2Cyclin D2Cyclin-Dependent KinasesKDR protein, humanReceptors, LysosphingolipidReceptors, Vascular Endothelial Growth FactorSphingolipidstransient receptor potential cation channel, subfamily C, member 1TRPC Cation ChannelsVascular Endothelial Growth Factor Receptor-2cancerreceptorsphingosine-1-phosphate (S1P)thyroidtransient receptor potential channels (TRP channels)vascular endothelial growth factor (VEGF)

Identifiers

PMID25971967
PMCPMC4481213
OpenAlexW2414430735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.